T1	Participants 15 39	autism spectrum disorder
T2	Participants 340 431	children and adolescents with both ASD and attention-deficit/hyperactivity disorder (ADHD).
T3	Participants 451 499	97 patients 6-17 years of age, with ASD and ADHD
